메뉴 건너뛰기




Volumn 147, Issue 2, 2014, Pages 502-526

Guidelines on genetic evaluation and management of lynch syndrome: A consensus statement by the us multi-society task force on colorectal cancer

(15)  Giardiello, Francis M a   Allen, John I b   Axilbund, Jennifer E a   Boland, C Richard c   Burke, Carol A d   Burt, Randall W e   Church, James M d   Dominitz, Jason A f,g   Johnson, David A h   Kaltenbach, Tonya i   Levin, Theodore R j   Lieberman, David A k   Robertson, Douglas J l,m   Syngal, Sapna n,o,p   Rex, Douglas K q  


Author keywords

Colorectal Cancer; Genetic Testing; Lynch Syndrome

Indexed keywords

B RAF KINASE; MISMATCH REPAIR PROTEIN; PROTEIN MLH1;

EID: 84904701595     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.04.001     Document Type: Article
Times cited : (388)

References (164)
  • 2
    • 0033897183 scopus 로고    scopus 로고
    • Proportion of colorectal cancer risk that might be preventable in a cohort of middle-aged US men
    • E.A. Platz, W.C. Willett, and G.A. Colditz et al. Proportion of colorectal cancer risk that might be preventable in a cohort of middle-aged US men Cancer Causes Control 11 2000 579 588
    • (2000) Cancer Causes Control , vol.11 , pp. 579-588
    • Platz, E.A.1    Willett, W.C.2    Colditz, G.A.3
  • 3
    • 0034644185 scopus 로고    scopus 로고
    • Environmental and heritable factors in the causation of cancer - Analysis of cohorts of twins from Sweden, Denmark, and Finland
    • P. Lichtenstein, N.V. Holm, and P.K. Verkasalo Environmental and heritable factors in the causation of cancer - analysis of cohorts of twins from Sweden, Denmark, and Finland N Engl J Med 343 2000 78 85
    • (2000) N Engl J Med , vol.343 , pp. 78-85
    • Lichtenstein, P.1    Holm, N.V.2    Verkasalo, P.K.3
  • 4
    • 0032555020 scopus 로고    scopus 로고
    • Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening of the disease
    • L.A. Aaltonen, R. Salovaara, and P. Kristo et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening of the disease N Engl J Med 338 1998 1481 1487
    • (1998) N Engl J Med , vol.338 , pp. 1481-1487
    • Aaltonen, L.A.1    Salovaara, R.2    Kristo, P.3
  • 5
    • 33745658837 scopus 로고    scopus 로고
    • Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer
    • R.A. Barnetson, A. Tenesa, and S.M. Farrington et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer N Engl J Med 354 2006 2751 2763
    • (2006) N Engl J Med , vol.354 , pp. 2751-2763
    • Barnetson, R.A.1    Tenesa, A.2    Farrington, S.M.3
  • 6
    • 17944362664 scopus 로고    scopus 로고
    • Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)
    • H. Hampel, W.L. Frankel, and E. Martin et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer) N Engl J Med 352 2005 1851 1860
    • (2005) N Engl J Med , vol.352 , pp. 1851-1860
    • Hampel, H.1    Frankel, W.L.2    Martin, E.3
  • 7
    • 20244386395 scopus 로고    scopus 로고
    • Gastrointestinal Oncology Group of the Spanish Gastroenterology Association, accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer
    • V. Pinol, A. Castells, and M. Andreu et al. Gastrointestinal Oncology Group of the Spanish Gastroenterology Association, accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer JAMA 293 2005 1986 1994
    • (2005) JAMA , vol.293 , pp. 1986-1994
    • Pinol, V.1    Castells, A.2    Andreu, M.3
  • 8
    • 84904686752 scopus 로고    scopus 로고
    • Population-based molecular detection of hereditary nonpolyposis colorectal cancer
    • R. Salovaara, A. Loukkola, and P. Kristo et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer J Clin Oncol 182 2000 193 200
    • (2000) J Clin Oncol , vol.182 , pp. 193-200
    • Salovaara, R.1    Loukkola, A.2    Kristo, P.3
  • 9
    • 0013878809 scopus 로고
    • Hereditary factors in cancer. Study of two large midwestern kindreds
    • H.T. Lynch, M.W. Shaw, and C.W. Magnuson et al. Hereditary factors in cancer. Study of two large midwestern kindreds Arch Intern Med 117 1966 206 212
    • (1966) Arch Intern Med , vol.117 , pp. 206-212
    • Lynch, H.T.1    Shaw, M.W.2    Magnuson, C.W.3
  • 10
    • 0027742295 scopus 로고
    • The human mutator gene homolog hMSH2 and its association with hereditary nonpolyposis colon cancer
    • R. Fishel, M.K. Lescoe, and M.R.S. Rao et al. The human mutator gene homolog hMSH2 and its association with hereditary nonpolyposis colon cancer Cell 75 1993 1027 1038
    • (1993) Cell , vol.75 , pp. 1027-1038
    • Fishel, R.1    Lescoe, M.K.2    Rao, M.R.S.3
  • 11
    • 0027145633 scopus 로고
    • Mutations of a MutS homolog in hereditary non-polyposis colorectal cancer
    • F.S. Leach, N. Nicolaides, and N. Papadopoulos et al. Mutations of a MutS homolog in hereditary non-polyposis colorectal cancer Cell 75 1993 1215 1255
    • (1993) Cell , vol.75 , pp. 1215-1255
    • Leach, F.S.1    Nicolaides, N.2    Papadopoulos, N.3
  • 12
    • 0028350601 scopus 로고
    • Mutation of a mutL homolog in hereditary colon cancer
    • N. Papadopoulos, N.C. Nicolaides, and Y.-F. Wei et al. Mutation of a mutL homolog in hereditary colon cancer Science 263 1994 1625 1629
    • (1994) Science , vol.263 , pp. 1625-1629
    • Papadopoulos, N.1    Nicolaides, N.C.2    Wei, Y.-F.3
  • 13
    • 0028221943 scopus 로고
    • Mutations in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer
    • C.E. Bronner, S.M. Baker, and P.T. Morrison et al. Mutations in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer Nature 368 1994 258 261
    • (1994) Nature , vol.368 , pp. 258-261
    • Bronner, C.E.1    Baker, S.M.2    Morrison, P.T.3
  • 14
    • 84904686702 scopus 로고    scopus 로고
    • National Cancer Institute Accessed November 1, 2013
    • National Cancer Institute. Levels of evidence for cancer genetic studies (PDQ). 2012. Available at: http://www.cancer.gov/cancertopics/pdq/levels- evidence-genetics. Accessed November 1, 2013.
    • (2012) Levels of Evidence for Cancer Genetic Studies (PDQ)
  • 15
    • 43049113533 scopus 로고    scopus 로고
    • GRADE: An emerging consensus on rating quality of evidence and strength of recommendations
    • G.H. Guyatt, A.D. Oxman, and G.E. Vist et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 2008 924 926
    • (2008) BMJ , vol.336 , pp. 924-926
    • Guyatt, G.H.1    Oxman, A.D.2    Vist, G.E.3
  • 16
    • 0021328985 scopus 로고
    • Familial colonic cancer without antecedent polyposis
    • C.R. Boland, and F.J. Troncale Familial colonic cancer without antecedent polyposis Ann Intern Med 100 1984 700 701
    • (1984) Ann Intern Med , vol.100 , pp. 700-701
    • Boland, C.R.1    Troncale, F.J.2
  • 17
    • 79958071334 scopus 로고    scopus 로고
    • Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome
    • V. Bonadona, B. Bonaïti, and S. Olschwang et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome JAMA 30 2011 2304 2310
    • (2011) JAMA , vol.30 , pp. 2304-2310
    • Bonadona, V.1    Bonaïti, B.2    Olschwang, S.3
  • 18
    • 0031012805 scopus 로고    scopus 로고
    • Cancer risk associated with germline DNA mismatch repair gene mutations
    • M.G. Dunlap, S.M. Farrington, and A.D. Carothers et al. Cancer risk associated with germline DNA mismatch repair gene mutations Hum Mol Genet 6 1997 105 110
    • (1997) Hum Mol Genet , vol.6 , pp. 105-110
    • Dunlap, M.G.1    Farrington, S.M.2    Carothers, A.D.3
  • 19
    • 20544467125 scopus 로고    scopus 로고
    • Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: Correction for ascertainment
    • F. Quehenberger, H.F. Vasen, and H.C. van Houwelingen Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment J Med Genet 42 2005 491 496
    • (2005) J Med Genet , vol.42 , pp. 491-496
    • Quehenberger, F.1    Vasen, H.F.2    Van Houwelingen, H.C.3
  • 20
    • 33645826906 scopus 로고    scopus 로고
    • Cancer risks for mismatch repair gene mutation carriers: A population-based early onset care-family study
    • M.A. Jenkins, L. Baglietto, and J.G. Dowty et al. Cancer risks for mismatch repair gene mutation carriers: a population-based early onset care-family study Clin Gastroenterol Hepatol 4 2006 489 498
    • (2006) Clin Gastroenterol Hepatol , vol.4 , pp. 489-498
    • Jenkins, M.A.1    Baglietto, L.2    Dowty, J.G.3
  • 21
    • 34547205071 scopus 로고    scopus 로고
    • Estimating cancer risk in HNPCC by the BRL method
    • F. Alarcon, C. Lasset, and J. Carayol et al. Estimating cancer risk in HNPCC by the BRL method Eur J Hum Genet 15 2007 831 836
    • (2007) Eur J Hum Genet , vol.15 , pp. 831-836
    • Alarcon, F.1    Lasset, C.2    Carayol, J.3
  • 22
    • 76349108011 scopus 로고    scopus 로고
    • Risks of Lynch syndrome cancers for MSH6 mutation carriers
    • L. Baglietto, N.M. Lindor, and J.G. Dowty et al. Risks of Lynch syndrome cancers for MSH6 mutation carriers J Natl Cancer Inst 102 2010 193 201
    • (2010) J Natl Cancer Inst , vol.102 , pp. 193-201
    • Baglietto, L.1    Lindor, N.M.2    Dowty, J.G.3
  • 23
    • 77951081566 scopus 로고    scopus 로고
    • Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in the colorectal cancer familial registry in Ontario
    • Y.H. Choi, M. Cotterchio, and G. McKeown-Eyssen et al. Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in the colorectal cancer familial registry in Ontario Hered Cancer Clin Pract 7 2009 14
    • (2009) Hered Cancer Clin Pract , vol.7 , pp. 14
    • Choi, Y.H.1    Cotterchio, M.2    McKeown-Eyssen, G.3
  • 24
    • 3242670404 scopus 로고    scopus 로고
    • Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: Impact on counseling and surveillance
    • Y.M. Hendriks, A. Wagner, and H. Morreau et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance Gastroenterology 127 2004 17 25
    • (2004) Gastroenterology , vol.127 , pp. 17-25
    • Hendriks, Y.M.1    Wagner, A.2    Morreau, H.3
  • 25
    • 48549099663 scopus 로고    scopus 로고
    • The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations
    • L. Senter, M. Clendenning, and K. Sotamaa et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations Gastroenterology 135 2008 419 428
    • (2008) Gastroenterology , vol.135 , pp. 419-428
    • Senter, L.1    Clendenning, M.2    Sotamaa, K.3
  • 26
    • 57449097359 scopus 로고    scopus 로고
    • Feasibility of screening for Lynch syndrome among patients with colorectal cancer
    • H. Hampel, W.L. Frankel, and E. Martin et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer J Clin Oncol 26 2008 5783 5788
    • (2008) J Clin Oncol , vol.26 , pp. 5783-5788
    • Hampel, H.1    Frankel, W.L.2    Martin, E.3
  • 27
    • 24144432339 scopus 로고    scopus 로고
    • Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)]
    • H.R. Vasen Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)] Fam Cancer 4 2005 219 225
    • (2005) Fam Cancer , vol.4 , pp. 219-225
    • Vasen, H.R.1
  • 28
    • 23244443650 scopus 로고    scopus 로고
    • Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: Later age of onset
    • H. Hampel, J.A. Stephens, and E. Pukkala et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset Gastroenterology 129 2005 415 421
    • (2005) Gastroenterology , vol.129 , pp. 415-421
    • Hampel, H.1    Stephens, J.A.2    Pukkala, E.3
  • 30
    • 0027248156 scopus 로고
    • Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An update review
    • H.T. Lynch, T.C. Smyrk, and P. Watson et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an update review Gastroenterology 104 1993 1535 1549
    • (1993) Gastroenterology , vol.104 , pp. 1535-1549
    • Lynch, H.T.1    Smyrk, T.C.2    Watson, P.3
  • 31
    • 0036906436 scopus 로고    scopus 로고
    • Survellance for hereditary nonpolyposis colorectal cancer: A long-term study of 114 families
    • W.H. de Vos tot Nederveen Cappel, F.M. Nagengast, and G. Griffioen et al. Survellance for hereditary nonpolyposis colorectal cancer: a long-term study of 114 families Dis Colon Rectum 45 2002 1588 1594
    • (2002) Dis Colon Rectum , vol.45 , pp. 1588-1594
    • De Vos Tot, N.C.W.H.1    Nagengast, F.M.2    Griffioen, G.3
  • 32
    • 79958200852 scopus 로고    scopus 로고
    • Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: The advantage of more extensive colon surgery
    • S. Parry, A.K. Win, and B. Parry et al. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery Gut 60 2011 950 957
    • (2011) Gut , vol.60 , pp. 950-957
    • Parry, S.1    Win, A.K.2    Parry, B.3
  • 33
    • 84878234117 scopus 로고    scopus 로고
    • Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers
    • A.K. Win, S. Parry, and B. Parry et al. Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers Ann Surg Oncol 20 2013 1829 1836
    • (2013) Ann Surg Oncol , vol.20 , pp. 1829-1836
    • Win, A.K.1    Parry, S.2    Parry, B.3
  • 34
    • 79952860470 scopus 로고    scopus 로고
    • Rapid development of colorectal neoplasia in patients with Lynch syndrome
    • D.L. Edelstein, J.E. Axilbund, and M. Baxter et al. Rapid development of colorectal neoplasia in patients with Lynch syndrome Clin Gastroenterol Hepatol 9 2011 340 343
    • (2011) Clin Gastroenterol Hepatol , vol.9 , pp. 340-343
    • Edelstein, D.L.1    Axilbund, J.E.2    Baxter, M.3
  • 35
    • 0028141683 scopus 로고
    • Hereditary nonpolyposis colorectal cancer - Morphologies, genes and mutations
    • J.R. Jass, S.M. Stewart, and J. Stewart et al. Hereditary nonpolyposis colorectal cancer - morphologies, genes and mutations Mut Res 310 1994 125 133
    • (1994) Mut Res , vol.310 , pp. 125-133
    • Jass, J.R.1    Stewart, S.M.2    Stewart, J.3
  • 36
    • 34447251079 scopus 로고    scopus 로고
    • Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: A population based study
    • M.A. Jenkins, S. Hayashi, and A.M. O'Shea et al. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population based study Gastroenterology 133 2007 48 56
    • (2007) Gastroenterology , vol.133 , pp. 48-56
    • Jenkins, M.A.1    Hayashi, S.2    O'Shea, A.M.3
  • 38
    • 0034642605 scopus 로고    scopus 로고
    • Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer
    • R. Gryfe, H. Kim, and E.T.K. Hsieh et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer N Engl J Med 342 2000 69 77
    • (2000) N Engl J Med , vol.342 , pp. 69-77
    • Gryfe, R.1    Kim, H.2    Hsieh, E.T.K.3
  • 39
    • 0032941343 scopus 로고    scopus 로고
    • Cancer risk in mutation carriers of DNA-mismatch-repair genes
    • M. Aarnio, R. Sankila, and E. Pukkala et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes Int J Cancer 81 1999 214 218
    • (1999) Int J Cancer , vol.81 , pp. 214-218
    • Aarnio, M.1    Sankila, R.2    Pukkala, E.3
  • 40
    • 0035886698 scopus 로고    scopus 로고
    • MSH2 mutation carriers are a higher risk for cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families
    • H.R. Vasen, A. Stormorken, and F.H. Menko et al. MSH2 mutation carriers are a higher risk for cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families J Clin Oncol 19 2001 4074 4080
    • (2001) J Clin Oncol , vol.19 , pp. 4074-4080
    • Vasen, H.R.1    Stormorken, A.2    Menko, F.H.3
  • 41
    • 33748796884 scopus 로고    scopus 로고
    • Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or kertoacanthomas
    • G. Ponti, L. Losi, and M. Pedroni et al. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or kertoacanthomas J Invest Dermatol 126 2006 2302 2307
    • (2006) J Invest Dermatol , vol.126 , pp. 2302-2307
    • Ponti, G.1    Losi, L.2    Pedroni, M.3
  • 42
    • 39649093644 scopus 로고    scopus 로고
    • The frequency of Muir-Torre syndrome among Lynch syndrome families
    • C.D. South, H. Hampel, and I. Comeras et al. The frequency of Muir-Torre syndrome among Lynch syndrome families J Natl Cancer Inst 100 2008 277 281
    • (2008) J Natl Cancer Inst , vol.100 , pp. 277-281
    • South, C.D.1    Hampel, H.2    Comeras, I.3
  • 43
    • 0034897120 scopus 로고    scopus 로고
    • The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer
    • P. Watson, R. Burzow, and H.T. Lynch et al. The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer Gynecol Oncol 82 2001 223 228
    • (2001) Gynecol Oncol , vol.82 , pp. 223-228
    • Watson, P.1    Burzow, R.2    Lynch, H.T.3
  • 44
    • 58849130663 scopus 로고    scopus 로고
    • Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: A report of 121 families with proven mutations
    • E. Barrow, L. Robinson, and W. Alduaij et al. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations Clin Genet 75 2009 141 149
    • (2009) Clin Genet , vol.75 , pp. 141-149
    • Barrow, E.1    Robinson, L.2    Alduaij, W.3
  • 45
    • 0030659081 scopus 로고    scopus 로고
    • Features of gastric cancer in hereditary non-polyposis colorectal cancer
    • M. Aarnio, R. Salovaara, and L.A. Aaltonen et al. Features of gastric cancer in hereditary non-polyposis colorectal cancer Int J Cancer 74 1997 551 555
    • (1997) Int J Cancer , vol.74 , pp. 551-555
    • Aarnio, M.1    Salovaara, R.2    Aaltonen, L.A.3
  • 46
    • 44949202465 scopus 로고    scopus 로고
    • The risk of extra-colonic, extra-endometrial cancer in Lynch syndrome
    • P. Watson, H.F. Vasen, and J.P. Mecklin et al. The risk of extra-colonic, extra-endometrial cancer in Lynch syndrome Int J Cancer 123 2008 444 449
    • (2008) Int J Cancer , vol.123 , pp. 444-449
    • Watson, P.1    Vasen, H.F.2    Mecklin, J.P.3
  • 47
    • 75149178659 scopus 로고    scopus 로고
    • Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands
    • L.G. Capelle, N.C. Van Grieken, and H.F. Lingsma et al. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands Gastroenterology 138 2010 487 492
    • (2010) Gastroenterology , vol.138 , pp. 487-492
    • Capelle, L.G.1    Van Grieken, N.C.2    Lingsma, H.F.3
  • 48
    • 84870747205 scopus 로고    scopus 로고
    • Risks of less common cancers in proven mutation carriers with lynch syndrome
    • C. Engel, M. Loeffler, and V. Steinke et al. Risks of less common cancers in proven mutation carriers with lynch syndrome J Clin Oncol 30 2012 4409 4415
    • (2012) J Clin Oncol , vol.30 , pp. 4409-4415
    • Engel, C.1    Loeffler, M.2    Steinke, V.3
  • 49
    • 77956105974 scopus 로고    scopus 로고
    • Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers
    • R.S. van der Post, L.A. Kiemeney, and M.J. Ligtenberg et al. Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers J Med Genet 47 2010 464 470
    • (2010) J Med Genet , vol.47 , pp. 464-470
    • Van Der Post, R.S.1    Kiemeney, L.A.2    Ligtenberg, M.J.3
  • 50
    • 54049097208 scopus 로고    scopus 로고
    • Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1914 individuals undergoing clinical genetic testing in the United States
    • F. Kastrinos, E.M. Stoffel, and J. Balmana et al. Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1914 individuals undergoing clinical genetic testing in the United States Cancer Epidemiol Biomarkers Prev 17 2008 2044 2051
    • (2008) Cancer Epidemiol Biomarkers Prev , vol.17 , pp. 2044-2051
    • Kastrinos, F.1    Stoffel, E.M.2    Balmana, J.3
  • 51
    • 84860605783 scopus 로고    scopus 로고
    • Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: A prospective cohort study
    • A.K. Win, J.P. Young, and N.M. Lindor Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study J Clin Oncol 30 2012 958 964
    • (2012) J Clin Oncol , vol.30 , pp. 958-964
    • Win, A.K.1    Young, J.P.2    Lindor, N.M.3
  • 52
    • 84904660223 scopus 로고    scopus 로고
    • Risk of pancreatic cancer in hereditary nonpolyposis colorectal cancer
    • Dusseldorf, Germany, June 24-27
    • Axilbund JE, Klein AP, Bacon JA, et al. Risk of pancreatic cancer in hereditary nonpolyposis colorectal cancer. Insight Meeting, Dusseldorf, Germany, June 24-27, 2009.
    • (2009) Insight Meeting
    • Axilbund, J.E.1    Klein, A.P.2    Bacon, J.A.3
  • 53
    • 70349321608 scopus 로고    scopus 로고
    • Germ-line mutations in mismatch repair genes associated with prostate cancer
    • E.M. Grindedal, P. Moller, and R. Eeles et al. Germ-line mutations in mismatch repair genes associated with prostate cancer Cancer Epidemiol Biomarkers Prev 18 2009 2460 2467
    • (2009) Cancer Epidemiol Biomarkers Prev , vol.18 , pp. 2460-2467
    • Grindedal, E.M.1    Moller, P.2    Eeles, R.3
  • 54
    • 70350733425 scopus 로고    scopus 로고
    • Risk of pancreatic cancer in families with Lynch syndrome
    • 1790-175
    • F. Kastrinos, B. Mukherjee, and N. Tayob et al. Risk of pancreatic cancer in families with Lynch syndrome JAMA 302 2009 1790-175
    • (2009) JAMA , vol.302
    • Kastrinos, F.1    Mukherjee, B.2    Tayob, N.3
  • 55
    • 0036173948 scopus 로고    scopus 로고
    • Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer
    • A. Muller, T.B. Edmonston, and D.A. Corao et al. Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer Cancer Res 62 2002 1014 1019
    • (2002) Cancer Res , vol.62 , pp. 1014-1019
    • Muller, A.1    Edmonston, T.B.2    Corao, D.A.3
  • 56
    • 0034989895 scopus 로고    scopus 로고
    • Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer?
    • H.F. Vasen, H. Morreau, and J.W. Nortier Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet 68 2001 1533 1535
    • (2001) Am J Hum Genet , vol.68 , pp. 1533-1535
    • Vasen, H.F.1    Morreau, H.2    Nortier, J.W.3
  • 57
    • 77950655236 scopus 로고    scopus 로고
    • Lynch syndrome-associated breast cancers: Clinicopathologic characteristics of a case series from the colon cancer family registry
    • M.D. Walsh, D.D. Buchanan, and M.C. Cummings et al. Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry Clin Cancer Res 16 2010 2214 2224
    • (2010) Clin Cancer Res , vol.16 , pp. 2214-2224
    • Walsh, M.D.1    Buchanan, D.D.2    Cummings, M.C.3
  • 58
    • 80455156386 scopus 로고    scopus 로고
    • Evidence for breast cancer as an integral part of Lynch syndrome
    • N. Buerki, L. Gautier, and M. Kovac et al. Evidence for breast cancer as an integral part of Lynch syndrome Genes Chromosomes Cancer 51 2012 83 91
    • (2012) Genes Chromosomes Cancer , vol.51 , pp. 83-91
    • Buerki, N.1    Gautier, L.2    Kovac, M.3
  • 59
    • 84879468424 scopus 로고    scopus 로고
    • Elevated risk of prostate cancer among men with Lynch syndrome
    • V.M. Raymond, B. Mukherjee, and F. Wang et al. Elevated risk of prostate cancer among men with Lynch syndrome J Clin Oncol 31 2013 1713 1718
    • (2013) J Clin Oncol , vol.31 , pp. 1713-1718
    • Raymond, V.M.1    Mukherjee, B.2    Wang, F.3
  • 60
    • 10944247543 scopus 로고    scopus 로고
    • Cancer genetics: Lesions from colorectal cancer
    • D.P. Kelsen, J.M. Daly, S.E. Kern, Lippincott William and Wilkins Philadelphia, PA
    • S.B. Gruber Cancer genetics: lesions from colorectal cancer D.P. Kelsen, J.M. Daly, S.E. Kern, Gastrointestinal oncology: principles and practice 2002 Lippincott William and Wilkins Philadelphia, PA 1635 1639
    • (2002) Gastrointestinal Oncology: Principles and Practice , pp. 1635-1639
    • Gruber, S.B.1
  • 61
    • 0036020964 scopus 로고    scopus 로고
    • Analysis of mismatch repair defects in the familial occurrence of lymphoma and colorectal cancer
    • J. Teruya-Feldstein, J. Greene, and L. Cohen et al. Analysis of mismatch repair defects in the familial occurrence of lymphoma and colorectal cancer Leuk Lymphoma 43 2002 1619 1626
    • (2002) Leuk Lymphoma , vol.43 , pp. 1619-1626
    • Teruya-Feldstein, J.1    Greene, J.2    Cohen, L.3
  • 62
    • 68449087753 scopus 로고    scopus 로고
    • Sarcomas associated with hereditary nonpolyposis colorectal cancer: Broad anatomical and morphologic spectrum
    • M. Nilbert, C. Therkildsen, and A. Nissen et al. Sarcomas associated with hereditary nonpolyposis colorectal cancer: broad anatomical and morphologic spectrum Fam Cancer 8 2009 209 213
    • (2009) Fam Cancer , vol.8 , pp. 209-213
    • Nilbert, M.1    Therkildsen, C.2    Nissen, A.3
  • 63
    • 0035770411 scopus 로고    scopus 로고
    • Cafe-au-lait spots and early onset colorectal neoplasia: A variant of HNPCC?
    • J.D. Trimbath, G.M. Petersen, and S.H. Erdman et al. Cafe-au-lait spots and early onset colorectal neoplasia: a variant of HNPCC? Fam Cancer 1 2001 101 105
    • (2001) Fam Cancer , vol.1 , pp. 101-105
    • Trimbath, J.D.1    Petersen, G.M.2    Erdman, S.H.3
  • 64
    • 78149280797 scopus 로고    scopus 로고
    • The gastrointestinal phenotype of germline biallelic mismatch repair gene mutations
    • C.A. Durno, S. Holter, and P.M. Sherman et al. The gastrointestinal phenotype of germline biallelic mismatch repair gene mutations Am J Gastroenterol 105 2010 2449 2456
    • (2010) Am J Gastroenterol , vol.105 , pp. 2449-2456
    • Durno, C.A.1    Holter, S.2    Sherman, P.M.3
  • 65
    • 0025848680 scopus 로고
    • The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer
    • H.F.A. Vasen, J.P. Mecklin, and P. Meera Khan et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer Dis Colon Rect 34 1991 424 425
    • (1991) Dis Colon Rect , vol.34 , pp. 424-425
    • Vasen, H.F.A.1    Mecklin, J.P.2    Meera Khan, P.3
  • 66
    • 0033063711 scopus 로고    scopus 로고
    • New criteria for hereditary non-polyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC (ICG-HNPCC)
    • H.F.A. Vasen, P. Watson, and J.P. Mecklin et al. New criteria for hereditary non-polyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC (ICG-HNPCC) Gastroenterology 116 1999 1453 1456
    • (1999) Gastroenterology , vol.116 , pp. 1453-1456
    • Vasen, H.F.A.1    Watson, P.2    Mecklin, J.P.3
  • 67
    • 10744233937 scopus 로고    scopus 로고
    • Revised Bethesda Guidelines for hereditary polyposis colorectal cancer (Lynch syndrome) and microsatellite instability
    • A. Umar, C.R. Boland, and J.P. Terdiman et al. Revised Bethesda Guidelines for hereditary polyposis colorectal cancer (Lynch syndrome) and microsatellite instability J Natl Cancer Inst 96 2004 261 268
    • (2004) J Natl Cancer Inst , vol.96 , pp. 261-268
    • Umar, A.1    Boland, C.R.2    Terdiman, J.P.3
  • 68
    • 84894353372 scopus 로고    scopus 로고
    • Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors
    • A.R. Mensenkamp, I.P. Vogelaar, and W.A.G. van Zelst-Stams et al. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors Gastroenterology 146 2014 643 646
    • (2014) Gastroenterology , vol.146 , pp. 643-646
    • Mensenkamp, A.R.1    Vogelaar, I.P.2    Van Zelst-Stams, W.A.G.3
  • 69
    • 20244386256 scopus 로고    scopus 로고
    • Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: Familial colorectal cancer type X
    • N.M. Lindor, K. Rabe, and G.M. Petersen et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X JAMA 293 2005 1979 1985
    • (2005) JAMA , vol.293 , pp. 1979-1985
    • Lindor, N.M.1    Rabe, K.2    Petersen, G.M.3
  • 70
    • 28144465438 scopus 로고    scopus 로고
    • Hereditary nonpolyposis colorectal cancer: Clinical and molecular evidence for a new entity of hereditary colorectal cancer
    • Y. Mueller-Koch, H. Vogelsang, and R. Koop et al. Hereditary nonpolyposis colorectal cancer: Clinical and molecular evidence for a new entity of hereditary colorectal cancer Gut 54 2005 1733 1740
    • (2005) Gut , vol.54 , pp. 1733-1740
    • Mueller-Koch, Y.1    Vogelsang, H.2    Koop, R.3
  • 71
    • 27144484911 scopus 로고    scopus 로고
    • Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway
    • X. Lior, E. Pons, and R.M. Xicola et al. Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway Clin Cancer Res 11 2005 7304 7310
    • (2005) Clin Cancer Res , vol.11 , pp. 7304-7310
    • Lior, X.1    Pons, E.2    Xicola, R.M.3
  • 72
    • 33947539706 scopus 로고    scopus 로고
    • Clinicopathologic and pedigree differences in Amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status
    • L. Valle, J. Perea, and P. Carbonell et al. Clinicopathologic and pedigree differences in Amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status J Clin Oncol 25 2007 781 786
    • (2007) J Clin Oncol , vol.25 , pp. 781-786
    • Valle, L.1    Perea, J.2    Carbonell, P.3
  • 73
    • 0019515269 scopus 로고
    • The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome
    • H.T. Lynch, P.M. Lynch, and J. Pester et al. The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome Arch Intern Med 141 1981 607 611
    • (1981) Arch Intern Med , vol.141 , pp. 607-611
    • Lynch, H.T.1    Lynch, P.M.2    Pester, J.3
  • 74
    • 0034031078 scopus 로고    scopus 로고
    • Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome
    • M.M. Entius, J.J. Keller, and P. Drillenburg et al. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome Clin Cancer Res 6 2000 1784 1789
    • (2000) Clin Cancer Res , vol.6 , pp. 1784-1789
    • Entius, M.M.1    Keller, J.J.2    Drillenburg, P.3
  • 75
    • 0028970197 scopus 로고
    • The molecular basis of Turcot's syndrome
    • S.R. Hamilton, B. Liu, and R.E. Parsons et al. The molecular basis of Turcot's syndrome N Engl J Med 332 1995 839 847
    • (1995) N Engl J Med , vol.332 , pp. 839-847
    • Hamilton, S.R.1    Liu, B.2    Parsons, R.E.3
  • 76
    • 0028221943 scopus 로고
    • Mutations in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer
    • C.E. Bronner, S.M. Baker, and P.T. Morrison et al. Mutations in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer Nature 368 1994 258 261
    • (1994) Nature , vol.368 , pp. 258-261
    • Bronner, C.E.1    Baker, S.M.2    Morrison, P.T.3
  • 77
    • 0027933070 scopus 로고
    • Mutations of two PMS homologues in hereditary nonpolyposis colon cancer
    • N.C. Nicolaides, N. Papadopoulos, and B. Liu et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer Nature 371 1994 75 80
    • (1994) Nature , vol.371 , pp. 75-80
    • Nicolaides, N.C.1    Papadopoulos, N.2    Liu, B.3
  • 78
    • 0030870631 scopus 로고    scopus 로고
    • Germ-line mutations of hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred
    • Y. Akiyama, H. Sato, and T. Yamada et al. Germ-line mutations of hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred Cancer Res 57 1997 3920 3923
    • (1997) Cancer Res , vol.57 , pp. 3920-3923
    • Akiyama, Y.1    Sato, H.2    Yamada, T.3
  • 79
    • 0031278322 scopus 로고    scopus 로고
    • Germline mutation of the hMSH6 gene as the cause of hereditary nonpolyposis colorectal cancer
    • M. Miyaki, M. Konishi, and K. Tanaka et al. Germline mutation of the hMSH6 gene as the cause of hereditary nonpolyposis colorectal cancer Nat Genet 17 1997 271 272
    • (1997) Nat Genet , vol.17 , pp. 271-272
    • Miyaki, M.1    Konishi, M.2    Tanaka, K.3
  • 80
    • 59749085710 scopus 로고    scopus 로고
    • Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome
    • M.E. Kovacs, J. Papp, and Z. Szentirmay et al. Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome Hum Mutat 30 2009 197 203
    • (2009) Hum Mutat , vol.30 , pp. 197-203
    • Kovacs, M.E.1    Papp, J.2    Szentirmay, Z.3
  • 81
    • 80053909171 scopus 로고    scopus 로고
    • Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion
    • H.T. Lynch, D.L. Riegert-Johnson, and C. Snyder et al. Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion Am J Gastroenterol 106 2011 1829 1836
    • (2011) Am J Gastroenterol , vol.106 , pp. 1829-1836
    • Lynch, H.T.1    Riegert-Johnson, D.L.2    Snyder, C.3
  • 82
    • 78650692633 scopus 로고    scopus 로고
    • Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: A cohort study
    • M.J. Kempers, R.P. Kuiper, and C.W. Ockeloen et al. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study Lancet Oncol 12 2011 49 55
    • (2011) Lancet Oncol , vol.12 , pp. 49-55
    • Kempers, M.J.1    Kuiper, R.P.2    Ockeloen, C.W.3
  • 83
    • 35348992639 scopus 로고    scopus 로고
    • The genetics of hereditary colon cancer
    • A.K. Rustgi The genetics of hereditary colon cancer Genes Dev 21 2007 2525 2538
    • (2007) Genes Dev , vol.21 , pp. 2525-2538
    • Rustgi, A.K.1
  • 84
    • 77951826608 scopus 로고    scopus 로고
    • Clinical analysis of PMS2: Mutation detection and avoidance of pseudogenes
    • C.P. Vaughn, J. Robles, and J.J. Swensen et al. Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes Hum Mutat 31 2010 588 593
    • (2010) Hum Mutat , vol.31 , pp. 588-593
    • Vaughn, C.P.1    Robles, J.2    Swensen, J.J.3
  • 85
    • 84883192504 scopus 로고    scopus 로고
    • Refining the role of pms2 in Lynch syndrome: Germline mutational analysis improved by comprehensive assessment of variants
    • E. Borràs, M. Pineda, and J. Cadiñanos et al. Refining the role of pms2 in Lynch syndrome: germline mutational analysis improved by comprehensive assessment of variants J Med Genet 50 2013 552 563
    • (2013) J Med Genet , vol.50 , pp. 552-563
    • Borràs, E.1    Pineda, M.2    Cadiñanos, J.3
  • 86
    • 72749085056 scopus 로고    scopus 로고
    • Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer
    • M.P. Hitchins, and R.L. Ward Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer J Med Genet 46 2009 793 802
    • (2009) J Med Genet , vol.46 , pp. 793-802
    • Hitchins, M.P.1    Ward, R.L.2
  • 87
    • 0027158031 scopus 로고
    • Clues to the pathogenesis of familial colorectal cancer
    • L.A. Aaltonen, P. Peltomaki, and F.S. Leach et al. Clues to the pathogenesis of familial colorectal cancer Science 260 1993 812 816
    • (1993) Science , vol.260 , pp. 812-816
    • Aaltonen, L.A.1    Peltomaki, P.2    Leach, F.S.3
  • 88
    • 0032534069 scopus 로고    scopus 로고
    • A National Cancer Institute Workshop of microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
    • C.R. Boland, S.N. Thibodeau, and S.R. Hamilton et al. A National Cancer Institute Workshop of microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Res 58 1998 5248 5257
    • (1998) Cancer Res , vol.58 , pp. 5248-5257
    • Boland, C.R.1    Thibodeau, S.N.2    Hamilton, S.R.3
  • 89
    • 0033361894 scopus 로고    scopus 로고
    • Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations
    • Y. Wu, M.J. Berends, and R.G. Mensink et al. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations Am J Hum Genet 65 1999 1291 1298
    • (1999) Am J Hum Genet , vol.65 , pp. 1291-1298
    • Wu, Y.1    Berends, M.J.2    Mensink, R.G.3
  • 90
    • 54249144723 scopus 로고    scopus 로고
    • Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer
    • A.C. Haugen, A. Goel, and K. Yamada et al. Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer Cancer Res 68 2008 8465 8472
    • (2008) Cancer Res , vol.68 , pp. 8465-8472
    • Haugen, A.C.1    Goel, A.2    Yamada, K.3
  • 91
    • 78049485430 scopus 로고    scopus 로고
    • Microsatellite alterations at selected tetranucleotide repeats are associated with morphologies of colorectal neoplasias
    • S.Y. Lee, H. Chung, and B. Devaraj et al. Microsatellite alterations at selected tetranucleotide repeats are associated with morphologies of colorectal neoplasias Gastroenterology 139 2010 1519 1525
    • (2010) Gastroenterology , vol.139 , pp. 1519-1525
    • Lee, S.Y.1    Chung, H.2    Devaraj, B.3
  • 92
    • 0038493613 scopus 로고    scopus 로고
    • Little evidence for involvement of MLH3 in colorectal cancer predisposition
    • T. Hienonen, P. Laiho, and R. Salovaara et al. Little evidence for involvement of MLH3 in colorectal cancer predisposition Int J Cancer 106 2003 292 296
    • (2003) Int J Cancer , vol.106 , pp. 292-296
    • Hienonen, T.1    Laiho, P.2    Salovaara, R.3
  • 93
    • 0037447157 scopus 로고    scopus 로고
    • The role of hMLH3 in familial colorectal cancer
    • H.X. Liu, X.L. Zhou, and T. Liu et al. The role of hMLH3 in familial colorectal cancer Cancer Res 63 2003 1894 1899
    • (2003) Cancer Res , vol.63 , pp. 1894-1899
    • Liu, H.X.1    Zhou, X.L.2    Liu, T.3
  • 94
    • 0037083484 scopus 로고    scopus 로고
    • Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors
    • N.M. Lindor, L.J. Burgart, and O. Leontovich et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors J Clin Oncol 20 2002 1043 1048
    • (2002) J Clin Oncol , vol.20 , pp. 1043-1048
    • Lindor, N.M.1    Burgart, L.J.2    Leontovich, O.3
  • 95
    • 84904687807 scopus 로고    scopus 로고
    • The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal cancers
    • J.M. Cunningham, C.Y. Kim, and E.R. Christensen et al. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal cancers Am J Hum Genet 68 2001 795 801
    • (2001) Am J Hum Genet , vol.68 , pp. 795-801
    • Cunningham, J.M.1    Kim, C.Y.2    Christensen, E.R.3
  • 96
    • 1642535480 scopus 로고    scopus 로고
    • BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer
    • G. Deng, I. Bell, and S. Crawley et al. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer Clin Cancer Res 10 2004 191 195
    • (2004) Clin Cancer Res , vol.10 , pp. 191-195
    • Deng, G.1    Bell, I.2    Crawley, S.3
  • 97
    • 20544437157 scopus 로고    scopus 로고
    • BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes
    • E. Domingo, R.C. Niessen, and C. Oliveria et al. BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes Oncogene 24 2005 3995 3998
    • (2005) Oncogene , vol.24 , pp. 3995-3998
    • Domingo, E.1    Niessen, R.C.2    Oliveria, C.3
  • 98
    • 67650000219 scopus 로고    scopus 로고
    • Efficient molecular screening of Lynch syndrome by specific 3′ promoter methylation of the MLH1 or BRAF mutation in colorectal cancer with high-frequency microsatellite instability
    • H. Nakagawa, T. Nagasake, and H.M. Culling et al. Efficient molecular screening of Lynch syndrome by specific 3′ promoter methylation of the MLH1 or BRAF mutation in colorectal cancer with high-frequency microsatellite instability Oncol Rep 21 2009 1577 1583
    • (2009) Oncol Rep , vol.21 , pp. 1577-1583
    • Nakagawa, H.1    Nagasake, T.2    Culling, H.M.3
  • 99
    • 51849147419 scopus 로고    scopus 로고
    • Gastrointestinal Oncology Group of the Spanish Gastroenterological Association, comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients
    • J. Balmana, F. Balaguer, and S. CastellviÍ-Bel et al. Gastrointestinal Oncology Group of the Spanish Gastroenterological Association, comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients J Med Genet 45 2008 557 563
    • (2008) J Med Genet , vol.45 , pp. 557-563
    • Balmana, J.1    Balaguer, F.2    Castellvií-Bel, S.3
  • 100
    • 62349128915 scopus 로고    scopus 로고
    • Prediction of Lynch syndrome in consecutive patients with colorectal cancer
    • R.C. Green, P.S. Parfrey, and M.O. Woods et al. Prediction of Lynch syndrome in consecutive patients with colorectal cancer J Natl Cancer Inst 101 2009 331 340
    • (2009) J Natl Cancer Inst , vol.101 , pp. 331-340
    • Green, R.C.1    Parfrey, P.S.2    Woods, M.O.3
  • 101
    • 66949163334 scopus 로고    scopus 로고
    • Development and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy
    • F. Kastrinos, J.I. Allen, and D.H. Stockwell et al. Development and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy Am J Gastroenterol 104 2009 1508 1518
    • (2009) Am J Gastroenterol , vol.104 , pp. 1508-1518
    • Kastrinos, F.1    Allen, J.I.2    Stockwell, D.H.3
  • 102
    • 74049157657 scopus 로고    scopus 로고
    • Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer
    • J.G. Monzon, C. Cremin, and L. Armstrong et al. Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer Int J Cancer 126 2010 930 939
    • (2010) Int J Cancer , vol.126 , pp. 930-939
    • Monzon, J.G.1    Cremin, C.2    Armstrong, L.3
  • 103
    • 77952681872 scopus 로고    scopus 로고
    • Report from the Jerusalem Workshop on Lynch syndrome - Hereditary nonpolyposis colorectal cancer
    • C.R. Boland, and M. Shike Report from the Jerusalem Workshop on Lynch syndrome - hereditary nonpolyposis colorectal cancer Gastroenterology 138 2010 2197 2201
    • (2010) Gastroenterology , vol.138 , pp. 2197-2201
    • Boland, C.R.1    Shike, M.2
  • 104
    • 33745658837 scopus 로고    scopus 로고
    • Identification and survival of carriers of mutations in DNA mismatch-repairs genes in colon cancer
    • R.A. Barnetson, A. Tenesa, and S.M. Farrington et al. Identification and survival of carriers of mutations in DNA mismatch-repairs genes in colon cancer N Engl J Med 354 2006 2751 2763
    • (2006) N Engl J Med , vol.354 , pp. 2751-2763
    • Barnetson, R.A.1    Tenesa, A.2    Farrington, S.M.3
  • 105
    • 78650513224 scopus 로고    scopus 로고
    • The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history
    • F. Kastrinos, E.W. Steyerberg, and R. Mercado et al. The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history Gastroenterology 2011 14073 14081
    • (2011) Gastroenterology , pp. 14073-14081
    • Kastrinos, F.1    Steyerberg, E.W.2    Mercado, R.3
  • 106
    • 78650801916 scopus 로고    scopus 로고
    • Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population
    • T.A. Dinh, B.I. Rosner, and J.C. Atwood et al. Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population Cancer Prev Res 4 2010 9 22
    • (2010) Cancer Prev Res , vol.4 , pp. 9-22
    • Dinh, T.A.1    Rosner, B.I.2    Atwood, J.C.3
  • 107
    • 84904704675 scopus 로고    scopus 로고
    • EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome
    • G.E. Palomaki, M.R. McClain, and S. Melillo et al. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome Genet Med 2009 1142 1165
    • (2009) Genet Med , pp. 1142-1165
    • Palomaki, G.E.1    McClain, M.R.2    Melillo, S.3
  • 108
    • 84872071989 scopus 로고    scopus 로고
    • Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer
    • F. Kastrinos, E.W. Steyerberg, and J. Balmaña et al. Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer Gut 62 2013 272 279
    • (2013) Gut , vol.62 , pp. 272-279
    • Kastrinos, F.1    Steyerberg, E.W.2    Balmaña, J.3
  • 109
    • 55349099844 scopus 로고    scopus 로고
    • Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): Revised Bethesda guidelines-based approach versus molecular screening
    • C. Julié, C. Trésallet, and A. Brouquet et al. Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening Am J Gastroenterol 103 2008 2825 2835
    • (2008) Am J Gastroenterol , vol.103 , pp. 2825-2835
    • Julié, C.1    Trésallet, C.2    Brouquet, A.3
  • 110
    • 84857993554 scopus 로고    scopus 로고
    • Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome
    • M.G. van Lier, C.H. Leenen, and A. Wagner et al. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome J Pathol 226 2012 764 774
    • (2012) J Pathol , vol.226 , pp. 764-774
    • Van Lier, M.G.1    Leenen, C.H.2    Wagner, A.3
  • 111
    • 84860555035 scopus 로고    scopus 로고
    • Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer
    • L. Pérez-Carbonell, C. Ruiz-Ponte, and C. Guarinos et al. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer Gut 61 2012 865 872
    • (2012) Gut , vol.61 , pp. 865-872
    • Pérez-Carbonell, L.1    Ruiz-Ponte, C.2    Guarinos, C.3
  • 112
    • 84867499525 scopus 로고    scopus 로고
    • Identification of Lynch syndrome among patients with colorectal cancer
    • L. Moreira, F. Balaguer, and N. Lindor et al. Identification of Lynch syndrome among patients with colorectal cancer JAMA 308 2012 1555 1565
    • (2012) JAMA , vol.308 , pp. 1555-1565
    • Moreira, L.1    Balaguer, F.2    Lindor, N.3
  • 113
    • 59849108362 scopus 로고    scopus 로고
    • Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality for Lynch syndrome in relatives
    • Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
    • Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality for Lynch syndrome in relatives Genet Med 11 2009 35 41
    • (2009) Genet Med , vol.11 , pp. 35-41
  • 114
    • 79960604164 scopus 로고    scopus 로고
    • Strategies to identify the Lynch syndrome among patients with colorectal cancer: A cost-effectiveness analysis
    • U. Ladabaum, G. Wang, and J. Terdiman et al. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis Ann Intern Med 155 2011 69 79
    • (2011) Ann Intern Med , vol.155 , pp. 69-79
    • Ladabaum, U.1    Wang, G.2    Terdiman, J.3
  • 115
    • 59849129653 scopus 로고    scopus 로고
    • EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality for Lynch syndrome
    • G.E. Palomaki, M.R. McClain, and S. Melillo et al. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality for Lynch syndrome Genet Med 11 2009 42 65
    • (2009) Genet Med , vol.11 , pp. 42-65
    • Palomaki, G.E.1    McClain, M.R.2    Melillo, S.3
  • 116
    • 77149122082 scopus 로고    scopus 로고
    • The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer
    • M. Mvundura, S.D. Grosse, and H. Hampel et al. The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer Genet Med 12 2010 93 104
    • (2010) Genet Med , vol.12 , pp. 93-104
    • Mvundura, M.1    Grosse, S.D.2    Hampel, H.3
  • 117
    • 84876079162 scopus 로고    scopus 로고
    • Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center
    • B. Heald, T. Plesec, and X. Liu et al. Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center J Clin Oncol 31 2013 1336 1340
    • (2013) J Clin Oncol , vol.31 , pp. 1336-1340
    • Heald, B.1    Plesec, T.2    Liu, X.3
  • 118
    • 78049472769 scopus 로고    scopus 로고
    • Genetic testing for hereditary colorectal cancer: Challenges in identifying, counseling, and managing high-risk patients
    • E.M. Stoffel, and A. Chitenden Genetic testing for hereditary colorectal cancer: challenges in identifying, counseling, and managing high-risk patients Gastroenterology 139 2010 1436 1441
    • (2010) Gastroenterology , vol.139 , pp. 1436-1441
    • Stoffel, E.M.1    Chitenden, A.2
  • 119
    • 0034950515 scopus 로고    scopus 로고
    • American Gastroenterological Association Medical Position Statement: Hereditary colorectal cancer and genetic testing
    • American Gastroenterological Association Medical Position Statement: hereditary colorectal cancer and genetic testing Gastroenterology 121 2001 195 197
    • (2001) Gastroenterology , vol.121 , pp. 195-197
  • 120
    • 0034955851 scopus 로고    scopus 로고
    • AGA technical review on hereditary colorectal cancer and genetic testing
    • F.M. Giardiello, J.D. Brensinger, and G.M. Petersen AGA technical review on hereditary colorectal cancer and genetic testing Gastroenterology 121 2001 198 213
    • (2001) Gastroenterology , vol.121 , pp. 198-213
    • Giardiello, F.M.1    Brensinger, J.D.2    Petersen, G.M.3
  • 121
    • 0034523949 scopus 로고    scopus 로고
    • Genetic testing for colon cancer: Joint statement of the American College of Medical Genetics and American Society of Human Genetics. Joint Test and Technology Transfer Committee Working Group
    • Genetic testing for colon cancer: joint statement of the American College of Medical Genetics and American Society of Human Genetics. Joint Test and Technology Transfer Committee Working Group Genet Med 2 2000 362 366
    • (2000) Genet Med , vol.2 , pp. 362-366
  • 123
    • 77649208372 scopus 로고    scopus 로고
    • American Society of Clinical Oncology policy statement update: Genetic and genomic testing for cancer susceptibility
    • M.E. Robson, C.D. Storm, and J. Weitzel et al. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility J Clin Oncol 28 2010 893 901
    • (2010) J Clin Oncol , vol.28 , pp. 893-901
    • Robson, M.E.1    Storm, C.D.2    Weitzel, J.3
  • 124
    • 0029864134 scopus 로고    scopus 로고
    • Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility
    • Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility J Clin Oncol 14 1996 1730 1740
    • (1996) J Clin Oncol , vol.14 , pp. 1730-1740
  • 125
    • 0032949239 scopus 로고    scopus 로고
    • Promoting safe and effective genetic testing in the United States: Work of the task force on genetic testing
    • N.A. Holtzman Promoting safe and effective genetic testing in the United States: work of the task force on genetic testing Clin Chem 45 1999 732 738
    • (1999) Clin Chem , vol.45 , pp. 732-738
    • Holtzman, N.A.1
  • 126
    • 23444445336 scopus 로고
    • Statement on use of DNA testing for presymptomatic identification of cancer risk
    • National Advisory Council for Human Genome Research
    • National Advisory Council for Human Genome Research Statement on use of DNA testing for presymptomatic identification of cancer risk J Am Med Assoc 271 1994 785
    • (1994) J Am Med Assoc , vol.271 , pp. 785
  • 128
    • 0036828652 scopus 로고    scopus 로고
    • Genetic testing and counseling for hereditary colorectal cancer
    • J.D. Trimbath, and F.M. Giardiello Genetic testing and counseling for hereditary colorectal cancer Aliment Pharmacol Ther 16 2002 1843 1857
    • (2002) Aliment Pharmacol Ther , vol.16 , pp. 1843-1857
    • Trimbath, J.D.1    Giardiello, F.M.2
  • 129
    • 0028900589 scopus 로고
    • Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer
    • H.J. Järvinen, J.P. Mecklin, and P. Sistonen Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer Gastroenterology 108 1995 1405 1411
    • (1995) Gastroenterology , vol.108 , pp. 1405-1411
    • Järvinen, H.J.1    Mecklin, J.P.2    Sistonen, P.3
  • 130
    • 0034011564 scopus 로고    scopus 로고
    • Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer
    • H.J. Järvinen, M. Aarnio, and H. Mustonen et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer Gastroenterology 118 2000 829 834
    • (2000) Gastroenterology , vol.118 , pp. 829-834
    • Järvinen, H.J.1    Aarnio, M.2    Mustonen, H.3
  • 131
    • 70350439453 scopus 로고    scopus 로고
    • Ten years after mutation testing for Lynch syndrome: Cancer incidence and outcome in mutation-positive and mutation-negative family members
    • H.J. Järvinen, L. Renkonen-Sinisalo, and K. Aktán- Collán et al. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members J Clin Oncol 27 2009 4793 4797
    • (2009) J Clin Oncol , vol.27 , pp. 4793-4797
    • Järvinen, H.J.1    Renkonen-Sinisalo, L.2    Aktán-Collán, K.3
  • 132
    • 27744477699 scopus 로고    scopus 로고
    • Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study
    • I. Dove-Edwin, P. Sasieni, and J. Adams et al. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study BMJ 331 2005 1047
    • (2005) BMJ , vol.331 , pp. 1047
    • Dove-Edwin, I.1    Sasieni, P.2    Adams, J.3
  • 133
    • 77952687174 scopus 로고    scopus 로고
    • One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome
    • H.F. Vasen, M. Abdirahman, and R. Brohet et al. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome Gastroenterology 138 2010 2300 2306
    • (2010) Gastroenterology , vol.138 , pp. 2300-2306
    • Vasen, H.F.1    Abdirahman, M.2    Brohet, R.3
  • 134
    • 75349092528 scopus 로고    scopus 로고
    • Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer
    • C. Engel, N. Rahner, and K. Schulmann et al. Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer Clin Gastroenterol Hepatol 8 2010 174 182
    • (2010) Clin Gastroenterol Hepatol , vol.8 , pp. 174-182
    • Engel, C.1    Rahner, N.2    Schulmann, K.3
  • 135
    • 84867626328 scopus 로고    scopus 로고
    • Impact of colonoscopic screening in male and female Lynch syndrome carriers with an MSH2 mutation
    • S. Stuckless, J.S. Green, and M. Morgenstern et al. Impact of colonoscopic screening in male and female Lynch syndrome carriers with an MSH2 mutation Clin Genet 82 2012 439 445
    • (2012) Clin Genet , vol.82 , pp. 439-445
    • Stuckless, S.1    Green, J.S.2    Morgenstern, M.3
  • 136
    • 76549087680 scopus 로고    scopus 로고
    • Risk assessment, genetic testing and management of Lynch syndrome
    • S. Grover, and S. Sygal Risk assessment, genetic testing and management of Lynch syndrome J NCCN 8 2010 98 105
    • (2010) J NCCN , vol.8 , pp. 98-105
    • Grover, S.1    Sygal, S.2
  • 137
    • 33749067855 scopus 로고    scopus 로고
    • Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: A systematic review
    • N.M. Lindor, G.M. Petersen, and D.W. Hadley et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review JAMA 2006 1507 1517
    • (2006) JAMA , pp. 1507-1517
    • Lindor, N.M.1    Petersen, G.M.2    Hadley, D.W.3
  • 138
    • 84876900933 scopus 로고    scopus 로고
    • Revised guidelines for the clinical management of Lynch syndrome (HNPCC): Recommendations by a group of European experts
    • H.F.A. Vasen, I. Blanco, and K. Aktan-Collan et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts Gut 62 2013 812 823
    • (2013) Gut , vol.62 , pp. 812-823
    • Vasen, H.F.A.1    Blanco, I.2    Aktan-Collan, K.3
  • 139
    • 0037086654 scopus 로고    scopus 로고
    • The outcome of endometrial carcinoma surveillance by ultrasound in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma
    • I. Dove-Edwin, D. Boks, and S. Goff et al. The outcome of endometrial carcinoma surveillance by ultrasound in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma Cancer 94 2002 1708 1712
    • (2002) Cancer , vol.94 , pp. 1708-1712
    • Dove-Edwin, I.1    Boks, D.2    Goff, S.3
  • 140
    • 0141534443 scopus 로고    scopus 로고
    • Gynecologic screening in hereditary nonpolyposis colorectal cancer
    • F.E. Rijcken, M.J. Mourits, and J.H. Kleibeuker et al. Gynecologic screening in hereditary nonpolyposis colorectal cancer Gynecol Oncol 91 2003 74 80
    • (2003) Gynecol Oncol , vol.91 , pp. 74-80
    • Rijcken, F.E.1    Mourits, M.J.2    Kleibeuker, J.H.3
  • 141
    • 33846619639 scopus 로고    scopus 로고
    • Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome
    • L. Renkonen-Sinisalo, R. Butzow, and A. Leminen et al. Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome Int J Cancer 120 2007 821 824
    • (2007) Int J Cancer , vol.120 , pp. 821-824
    • Renkonen-Sinisalo, L.1    Butzow, R.2    Leminen, A.3
  • 142
    • 55949125912 scopus 로고    scopus 로고
    • Performance of office hysteroscopy and endometrial biopsy for detecting endometrial disease in women at risk of human non-polyposis colon cancer: A prospective study
    • F. Lécuru, M.A. Le Frère Belda, and A.S. Bats et al. Performance of office hysteroscopy and endometrial biopsy for detecting endometrial disease in women at risk of human non-polyposis colon cancer: a prospective study Int J Gynecol Cancer 18 2008 1326 1331
    • (2008) Int J Gynecol Cancer , vol.18 , pp. 1326-1331
    • Lécuru, F.1    Le Frère Belda, M.A.2    Bats, A.S.3
  • 143
    • 70449519168 scopus 로고    scopus 로고
    • Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome
    • L.H. Gerritzen, N. Hoogerbrugge, and A.L. Oei et al. Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome Fam Cancer 8 2009 391 397
    • (2009) Fam Cancer , vol.8 , pp. 391-397
    • Gerritzen, L.H.1    Hoogerbrugge, N.2    Oei, A.L.3
  • 144
    • 84874983859 scopus 로고    scopus 로고
    • Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation
    • S. Stuckless, J. Green, and L. Dawson et al. Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation Clin Genet 83 2013 359 364
    • (2013) Clin Genet , vol.83 , pp. 359-364
    • Stuckless, S.1    Green, J.2    Dawson, L.3
  • 145
    • 69749116285 scopus 로고    scopus 로고
    • Screening for familial ovarian cancer: Poor survival of BRCA1/2 related cancers
    • D.G. Evans, K.N. Gaarenstroom, and D. Stirling et al. Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers J Med Genet 46 2009 593 597
    • (2009) J Med Genet , vol.46 , pp. 593-597
    • Evans, D.G.1    Gaarenstroom, K.N.2    Stirling, D.3
  • 146
    • 30944457531 scopus 로고    scopus 로고
    • Prophylactic surgery to reduce the risk of gynecological cancers in Lynch syndrome
    • K.M. Schmeler, H.T. Lynch, and L.M. Chen et al. Prophylactic surgery to reduce the risk of gynecological cancers in Lynch syndrome N Engl J Med 354 2006 261 269
    • (2006) N Engl J Med , vol.354 , pp. 261-269
    • Schmeler, K.M.1    Lynch, H.T.2    Chen, L.M.3
  • 147
    • 80055001120 scopus 로고    scopus 로고
    • A cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) families
    • K.Y. Yang, A.B. Caughey, and S.E. Little et al. A cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) families Fam Cancer 10 2011 535 543
    • (2011) Fam Cancer , vol.10 , pp. 535-543
    • Yang, K.Y.1    Caughey, A.B.2    Little, S.E.3
  • 148
    • 48249113933 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome
    • J.S. Kwon, C.C. Sun, and S.K. Peterson et al. Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome Cancer 113 2008 326 335
    • (2008) Cancer , vol.113 , pp. 326-335
    • Kwon, J.S.1    Sun, C.C.2    Peterson, S.K.3
  • 149
    • 0036000213 scopus 로고    scopus 로고
    • No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer
    • L. Renkonen-Sinisalo, P. Sipponen, and M. Aarnio et al. No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer Scand J Gastroenterol 37 2002 574 577
    • (2002) Scand J Gastroenterol , vol.37 , pp. 574-577
    • Renkonen-Sinisalo, L.1    Sipponen, P.2    Aarnio, M.3
  • 150
    • 20244387702 scopus 로고    scopus 로고
    • HNPCC-associated small bowel cancer: Clinical and molecular characteristics
    • K. Schulmann, F.E. Brasch, and E. Kunstmann et al. HNPCC-associated small bowel cancer: clinical and molecular characteristics Gastroenterology 128 2005 590 599
    • (2005) Gastroenterology , vol.128 , pp. 590-599
    • Schulmann, K.1    Brasch, F.E.2    Kunstmann, E.3
  • 151
    • 78649812903 scopus 로고    scopus 로고
    • Small-bowel capsule endoscopy diagnoses early and advanced neoplasms in asymptomatic patients with Lynch syndrome
    • J.C. Saurin, F. Pilleul, and E.B. Soussan et al. Small-bowel capsule endoscopy diagnoses early and advanced neoplasms in asymptomatic patients with Lynch syndrome Endoscopy 42 2010 1057 1062
    • (2010) Endoscopy , vol.42 , pp. 1057-1062
    • Saurin, J.C.1    Pilleul, F.2    Soussan, E.B.3
  • 152
    • 55949121061 scopus 로고    scopus 로고
    • Screening for urinary tract cancer with urine cytology in Lynch syndrome and familial colorectal cancer
    • T. Myrhøj, M.B. Andersen, and I. Bernstein Screening for urinary tract cancer with urine cytology in Lynch syndrome and familial colorectal cancer Fam Cancer 7 2008 303 307
    • (2008) Fam Cancer , vol.7 , pp. 303-307
    • Myrhøj, T.1    Andersen, M.B.2    Bernstein, I.3
  • 153
    • 70350090521 scopus 로고    scopus 로고
    • Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome
    • E. Stoffel, B. Mukherjee, and V.M. Raymond et al. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome Gastroenterology 137 2009 1621 1627
    • (2009) Gastroenterology , vol.137 , pp. 1621-1627
    • Stoffel, E.1    Mukherjee, B.2    Raymond, V.M.3
  • 154
    • 0025035544 scopus 로고
    • Bladder cancer screening among primary aluminum production workers in Quebec
    • G.P. Thériault, C.G. Tremblay, and B.G. Armstrong Bladder cancer screening among primary aluminum production workers in Quebec J Occup Med 32 1990 869 872
    • (1990) J Occup Med , vol.32 , pp. 869-872
    • Thériault, G.P.1    Tremblay, C.G.2    Armstrong, B.G.3
  • 155
    • 84904706145 scopus 로고    scopus 로고
    • Office of Disease Prevention and Health Promotion Accessed November 1, 2013
    • Office of Disease Prevention and Health Promotion. Screening for bladder cancer. Available at: http://odphp.osophs.dhhs.gov/pubs/guidecps/PDF/CH17.PDF. Accessed November 1, 2013.
    • Screening for Bladder Cancer
  • 156
    • 84873412474 scopus 로고    scopus 로고
    • International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer International Cancer of Pancreas Screening (CAPS) Consortium
    • M.I. Canto, F. Harinck, and R.H. Hruban et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer International Cancer of Pancreas Screening (CAPS) Consortium Gut 62 2013 339 347
    • (2013) Gut , vol.62 , pp. 339-347
    • Canto, M.I.1    Harinck, F.2    Hruban, R.H.3
  • 157
    • 84873414349 scopus 로고    scopus 로고
    • The spectrum of urological malignancy in Lynch syndrome
    • P.J. Barrow, S. Ingham, and C. O'Hara et al. The spectrum of urological malignancy in Lynch syndrome Fam Cancer 12 2013 57 63
    • (2013) Fam Cancer , vol.12 , pp. 57-63
    • Barrow, P.J.1    Ingham, S.2    O'Hara, C.3
  • 158
    • 84863632927 scopus 로고    scopus 로고
    • Quality of life after surgery for colon cancer in patients with Lynch syndrome: Partial versus subtotal colectomy
    • J.F. Haanstra, W.H. de Vos Tot Nederveen Cappel, and J.P. Gopie et al. Quality of life after surgery for colon cancer in patients with Lynch syndrome: partial versus subtotal colectomy Dis Colon Rectum 55 2012 653 659
    • (2012) Dis Colon Rectum , vol.55 , pp. 653-659
    • Haanstra, J.F.1    De Vos Tot, N.C.W.H.2    Gopie, J.P.3
  • 159
    • 10744233669 scopus 로고    scopus 로고
    • Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect
    • W.H. de Vos tot Nederveen Cappel, E. Buskens, and P. van Duijvendijk et al. Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect Gut 52 2003 1752 1755
    • (2003) Gut , vol.52 , pp. 1752-1755
    • De Vos Tot, N.C.W.H.1    Buskens, E.2    Van Duijvendijk, P.3
  • 160
    • 84861343006 scopus 로고    scopus 로고
    • Risk of colonic neoplasia after proctectomy for rectal cancer in hereditary nonpolyposis colorectal cancer
    • M.F. Kalady, J. Lipman, and E. McGannon et al. Risk of colonic neoplasia after proctectomy for rectal cancer in hereditary nonpolyposis colorectal cancer Ann Surg 255 2012 1121 1125
    • (2012) Ann Surg , vol.255 , pp. 1121-1125
    • Kalady, M.F.1    Lipman, J.2    McGannon, E.3
  • 161
    • 57749107623 scopus 로고    scopus 로고
    • Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome
    • J. Burn, D.T. Bishop, and J.P. Mecklin et al. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome N Engl J Med 359 2008 2567 2578
    • (2008) N Engl J Med , vol.359 , pp. 2567-2578
    • Burn, J.1    Bishop, D.T.2    Mecklin, J.P.3
  • 162
    • 84870242223 scopus 로고    scopus 로고
    • Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomized controlled trial
    • J.C. Mathers, M. Movahedi, and F. Macrae et al. Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomized controlled trial Lancet Oncol 13 2012 1242 1249
    • (2012) Lancet Oncol , vol.13 , pp. 1242-1249
    • Mathers, J.C.1    Movahedi, M.2    Macrae, F.3
  • 163
    • 83955161674 scopus 로고    scopus 로고
    • Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomized controlled trial
    • J. Burn, A.M. Gerdes, and F. Macrae et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomized controlled trial Lancet 378 2011 2081 2087
    • (2011) Lancet , vol.378 , pp. 2081-2087
    • Burn, J.1    Gerdes, A.M.2    Macrae, F.3
  • 164
    • 78650825618 scopus 로고    scopus 로고
    • Effect of daily aspirin on long-term risk of death due to cancer: Analysis of individual patient data from randomized trials
    • P.M. Rothwell, F.G. Fowkes, and J.F. Belch et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomized trials Lancet 377 2011 31 41
    • (2011) Lancet , vol.377 , pp. 31-41
    • Rothwell, P.M.1    Fowkes, F.G.2    Belch, J.F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.